Keylika

We focus on the critical intersection of drug discovery and drug delivery, employing AI-enabled de novo drug design and cutting edge nanotechnology-based transdermal delivery technologies, to generate best-in-class, breakthrough therapies. Source (opens in a new tab)

Website

https://www.keylika.com/

Headquarters

US